Clinical Research Directory
Browse clinical research sites, groups, and studies.
Prophylactic Tranexamic Acid To Reduce Blood Loss During Caesarean Delivery.
Sponsor: Aligarh Muslim University
Summary
Postpartum hemorrhage continues to be the leading cause of maternal morbidity and mortality. Globally, it is responsible for 25% of all pregnancy-related deaths. PPH is unpredictable and may occur in the absence of risk factors. Tranexamic acid is an antifibrinolytic proven to reduce blood loss and transfusion requirements for various surgeries. This study aims to explore the effectiveness of tranexamic acid as an adjunct to other uterotonics before the Caesarian Section.
Official title: Prophylactic Role Of Tranexamic Acid To Reduce Blood Loss During Caesarean Delivery : A Prospective Study.
Key Details
Gender
FEMALE
Age Range
18 Years - 45 Years
Study Type
INTERVENTIONAL
Enrollment
300
Start Date
2024-10-01
Completion Date
2025-03-30
Last Updated
2024-10-24
Healthy Volunteers
No
Conditions
Interventions
Tranexamic acid injection
All women recruited to Group A will receive tranexamic acid 1 gram in 100 ml Normal Saline as intravenous infusion 10 minutes before the skin incision.
Placebo
All women recruited to Group B will receive 100 ml Normal Saline as intravenous infusion 10 minutes before the skin incision.
Locations (1)
ASJSATDS Medical College
Fatehpur, Uttar Pradesh, India